Is remote work here to stay for biopharma? Early indications point to yes

Covid-19 cases in the US have begun to ebb, following a nationwide vaccination campaign that has nearly 60% of American adults receiving at least one vaccine dose as of Tuesday. And with more and more individuals being inoculated, the biopharma industry is openly wondering how to bring its employees back...

Click to view original post